hyperchem professional release 7.0 (Hypercube Inc)
90
Structured Review
Hypercube Inc
hyperchem professional release 7.0
Hyperchem Professional Release 7.0, supplied by Hypercube Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hyperchem+professional+release+7%2E0/hyperchem/10__1039_slash_c1md00135c-503-1-11
Average 90 stars, based on 1 article reviews
Hyperchem Professional Release 7.0, supplied by Hypercube Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hyperchem+professional+release+7%2E0/hyperchem/10__1039_slash_c1md00135c-503-1-11
Average 90 stars, based on 1 article reviews
hyperchem professional release 7.0 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Exploring structural requirements of 1-N-substituted thiocarbamoyl-3-phenyl-2-pyrazolines as antiamoebic agents using comparative QSAR modelling. Article Snippet: 0960-894X/$ see front matter 2010 Elsevier Ltd. A doi:10.1016/j.bmcl.2010.05.098 * Corresponding author.. Tel.. : +91 33 24146666x249 E-mail address: tjupharm@yahoo.com (T. Jha). Article Title: Chemometric modeling and pharmacophore mapping in coronary heart disease: 2-arylbenzoxazoles as cholesteryl ester transfer protein inhibitors Article Snippet: The plasma concentration of HDL-C and the prevalence of coronary heart disease (CHD) is inversely related.. Inhibition of cholesteryl ester transfer protein (CETP) is considered to be a potential approach to treat dyslipidemia and CHD.. 2-arylbenzoxazoles were found to be a potential class of CETP inhibitors. |